People · Operator

George H. Holmes

Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology

1
Companies
1
Filings
$13.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Inanovate IncBiotechnologySeed$13.0M$2.6M2015
Operator network

George H. Holmes at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Peter D. Los · 2 companies · 1 sharedPeter D. LosBlaine D Crissman · 1 companies · 1 sharedBlaine D CrissmanDavid Arslanian · 1 companies · 1 sharedDavid ArslanianDavid D Arslanian · 1 companies · 1 sharedDavid D ArslanianDavid Ure · 1 companies · 1 sharedDavid UreGeorge D Holmes · 1 companies · 1 sharedGeorge D HolmesJames E Oury · 1 companies · 1 sharedJames E OuryJames H. Oury · 1 companies · 1 sharedJames H. OuryKamran D Tahamtanzade · 1 companies · 1 sharedKamran D Tahamtan…Katie D Pohlson · 1 companies · 1 sharedKatie D PohlsonKent D Lehr · 1 companies · 1 sharedKent D LehrMichael D Goldstein · 1 companies · 1 sharedMichael D Goldste…Michael H. Goldstein · 1 companies · 1 sharedMichael H. Goldst…Randall H. Marfin · 1 companies · 1 sharedRandall H. MarfinInanovate Inc · $13.0M raisedInanovate IncGeorge H. HolmesGH
George H. Holmes Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside George H. Holmes on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Peter D. Los12
Michael H. Goldstein11
David Ure11
Randall H. Marfin11
David Arslanian11
James H. Oury11
George D Holmes11
Blaine D Crissman11
David D Arslanian11
James E Oury11
Katie D Pohlson11
Kent D Lehr11
Kamran D Tahamtanzade11
Michael D Goldstein11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.